What does the Framingham Risk Score measure?

It estimates the probability of experiencing a cardiovascular event (coronary heart disease, stroke, peripheral artery disease, or heart failure) within the next 10 years. It does not predict other conditions and is designed for adults without known existing CVD.

What cholesterol units does this calculator use?

This calculator uses mg/dL, the unit used in the original Framingham tables. To convert from mmol/L to mg/dL, multiply by 38.67 for cholesterol. Typical total cholesterol in a healthy adult is 150–200 mg/dL; HDL above 60 mg/dL is considered protective.

What are the Framingham risk categories?

For readability, this calculator labels estimates below 10% as low, 10–20% as intermediate, and above 20% as high. These display bands are not treatment rules from the 2008 point table. A clinician should interpret the estimate using current prevention guidelines and the patient's complete history.

Why are there separate tables for men and women?

Men and women have different baseline cardiovascular risk profiles and different relationships between risk factors and CVD events. The Framingham study derived sex-specific regression coefficients, so combining them into one table would produce inaccurate estimates.

Is this calculator a substitute for clinical advice?

No. The Framingham Risk Score is a decision-support tool, not a replacement for a physician's evaluation. Risk estimates should be interpreted alongside the patient's full medical history, family history, and other biomarkers. All treatment decisions must be made by a qualified clinician.

What age range was used to derive the Framingham score?

The 2008 General CVD model was derived from Framingham participants aged 30–74 years who were free of CVD at baseline. This calculator therefore accepts ages 30–74 and should not be extrapolated outside that range.

Framingham Risk Score Calculator

Enter age, total cholesterol, HDL, systolic blood pressure, smoking status, and diabetes to estimate your 10-year cardiovascular disease risk using the Framingham point-score algorithm.

Patient Information

Biological Sex

Male Female

Age (years, 30–74)

Total Cholesterol (mg/dL)

HDL Cholesterol (mg/dL)

Systolic Blood Pressure (mmHg)

Currently on blood pressure medication

Current smoker

Diabetes diagnosis

Fill in the fields and click Calculate

Clinical note: This tool implements the Framingham Heart Study point-score algorithm (D'Agostino et al., 2008). Results are for educational purposes only and are not a substitute for professional medical advice. Consult a qualified clinician before making any treatment decisions.

Summary

The 2008 Framingham General Cardiovascular Risk Profile estimates an individual's 10-year risk of a first cardiovascular disease (CVD) event, including coronary heart disease, stroke or transient ischemic attack, peripheral artery disease, and heart failure. This calculator implements the published sex-specific point score using age, total cholesterol, HDL cholesterol, systolic blood pressure (and whether it is being treated), smoking status, and diabetes diagnosis. It is intended for primary-prevention adults without known CVD and can support — but not determine — clinical prevention decisions.

How it works

Select your biological sex (male or female) — the Framingham algorithm uses separate scoring tables for each.
Enter your age in years (30–74, the population studied for this model).
Enter your total cholesterol and HDL cholesterol values in mg/dL.
Enter your systolic blood pressure in mmHg and indicate whether you are currently on blood pressure treatment.
Check "Current smoker" if you smoke cigarettes and "Diabetes" if you have a diabetes diagnosis.
Click "Calculate 10-Year CVD Risk" to display your estimated 10-year risk percentage, risk category, and point breakdown.

Use cases

Estimate personal 10-year cardiovascular risk before a doctor's appointment.
Understand how cholesterol, blood pressure, and smoking each contribute to heart risk.
Track how lifestyle changes (quitting smoking, lowering cholesterol) reduce estimated CVD risk over time.
Support a clinician-patient discussion about cardiovascular prevention options.
Educate patients on modifiable risk factors for cardiovascular disease.
Compare risk between treated and untreated hypertension scenarios.

Frequently Asked Questions

Last updated: 2026-09-30 · Reviewed by Nham Vu